Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Ketamine Prolonged Release Tablets
NCT02494830Phase 1Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Aug 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in pain, sponsored by Universitätsklinikum Greifswald. Primary endpoint: Bioavailability (F) up to 60 hours. Started Aug 2014; status: completed.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT02494830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494830.